Alector, Inc. (ALEC)
2.505
-0.22
(-7.90%)
USD |
NASDAQ |
Sep 03, 16:00
2.50
0.00 (0.00%)
After-Hours: 18:24
Alector Total Liabilities (Quarterly) : 212.82M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 212.82M |
| March 31, 2026 | 229.53M |
| December 31, 2025 | 262.59M |
| September 30, 2025 | 277.57M |
| June 30, 2025 | 285.25M |
| March 31, 2025 | 313.69M |
| December 31, 2024 | 341.50M |
| September 30, 2024 | 397.09M |
| June 30, 2024 | 420.16M |
| March 31, 2024 | 456.59M |
| December 31, 2023 | 487.67M |
| September 30, 2023 | 509.84M |
| June 30, 2023 | 512.43M |
| March 31, 2023 | 565.33M |
| December 31, 2022 | 573.21M |
| September 30, 2022 | 583.93M |
| June 30, 2022 | 601.16M |
| March 31, 2022 | 686.92M |
| Date | Value |
|---|---|
| December 31, 2021 | 513.93M |
| September 30, 2021 | 518.34M |
| June 30, 2021 | 212.60M |
| March 31, 2021 | 212.54M |
| December 31, 2020 | 220.72M |
| September 30, 2020 | 221.40M |
| June 30, 2020 | 216.70M |
| March 31, 2020 | 227.19M |
| December 31, 2019 | 227.17M |
| September 30, 2019 | 231.14M |
| June 30, 2019 | 231.54M |
| March 31, 2019 | 229.86M |
| December 31, 2018 | 195.24M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 210.61M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.661B |
| Anixa Biosciences, Inc. | 1.641M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 202.86M |
| Shareholders Equity (Quarterly) | -9.97M |
| Debt to Equity Ratio | -3.286 |
| Current Ratio | 5.260 |
| Net Debt Paydown Yield | 0.74% |